Ignite Creation Date:
2025-12-24 @ 12:41 PM
Ignite Modification Date:
2026-01-29 @ 6:04 AM
Study NCT ID:
NCT03797261
Status:
TERMINATED
Last Update Posted:
2021-12-07
First Post:
2019-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-18
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-07
First Submit QC Date:
None
Study First Post Date:
2019-01-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-03
Last Update Post Date:
2021-12-07
Last Update Post Date Type:
ACTUAL